Market Overview Of Prosthetic joint infections Industry Clinical Trials Review, H2, 2017

Overview

Prosthetic joint infection (PJI) is one of the most serious complications of prosthetic joint implantation. Symptoms include pain or stiffness in joints, swelling, redness around the wound, fatigue and fever. Risk factors include age, prior arthroplasty, poor nutritional status, obesity, diabetes mellitus and advanced HIV disease. Treatment includes antimicrobial therapy.

 Click here for sample report @ http://www.wiseguyreports.com/sample-request/2740071-prosthetic-joint-infections-pipeline-review-h2-2017

Report Highlights

The Pharmaceutical and Healthcare latest pipeline guide Prosthetic joint infections - Pipeline Review, H2 2017, provides comprehensive information on the therapeutics under development for Prosthetic joint infections (Musculoskeletal Disorders), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Prosthetic joint infections (Musculoskeletal Disorders) pipeline guide also reviews of key players involved in therapeutic development for Prosthetic joint infections and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase III, Phase I, Preclinical, Discovery and Unknown stages are 1, 1, 4, 1 and 1 respectively.

 Major Scope of the report:

- The pipeline guide provides a snapshot of the global therapeutic landscape of Prosthetic joint infections (Musculoskeletal Disorders). 
- The pipeline guide reviews pipeline therapeutics for Prosthetic joint infections (Musculoskeletal Disorders) by companies and universities/research institutes based on information derived from company and industry-specific sources. 
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages. 
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities. 
- The pipeline guide reviews key companies involved in Prosthetic joint infections (Musculoskeletal Disorders) therapeutics and enlists all their major and minor projects. 

Table of Contents 

List of Tables 
List of Figures 
Introduction 
Global Markets Direct Report Coverage 
Prosthetic joint infections - Overview 
Prosthetic joint infections - Therapeutics Development 
Pipeline Overview 
Pipeline by Companies 
Products under Development by Companies 
Prosthetic joint infections - Therapeutics Assessment 
Assessment by Target 
Assessment by Mechanism of Action 
Assessment by Route of Administration 
Assessment by Molecule Type 
Prosthetic joint infections - Companies Involved in Therapeutics Development 
AmpliPhi Biosciences Corp 
Melinta Therapeutics Inc 
Motif Bio Plc 
Nabriva Therapeutics plc 
Telephus Medical LLC 
Prosthetic joint infections - Drug Profiles 
ABSA-01 - Drug Profile  

.Continued

For Detailed Reading Please visit @ https://www.wiseguyreports.com/reports/2740071-prosthetic-joint-infections-pipeline-review-h2-2017

Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs.

WISEGUY RESEARCH CONSULTANTS PVT LTD
Office No. 528, Amanora Chambers
Pune - 411028
Maharashtra, India

This release was published on openPR.